Nasal spray vs IV: which sedative better prevents Kids' Post-Dental agitation?
NCT ID NCT06466915
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This trial compares two drugs—propofol given intravenously and dexmedetomidine given as a nasal spray—to see which better prevents agitation and delirium in children waking up from dental surgery under general anesthesia. About 162 children aged 1-2 on the ASA scale will take part. The goal is to find a safer, more effective way to calm kids and avoid complications like bleeding or delayed discharge.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexmedetomidine (nasal) and propofol (intravenous)
- What this could lead to
- If one drug proves better at calming children after dental surgery, it could reduce complications like bleeding, IV dislodgement, and hospital delays.
- What could go wrong
- This is a single-center, moderate-sized trial. Results may not apply to all children or surgeries, and both drugs carry risks like breathing problems or unstable blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
162 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 year to 8 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA 1-2 Exclusion Criteria: * Cardiac disease, * Psychiatric disease, * Coronary artery disease, * Long-term sedative drug use, * Pulmonary disease, * Known allergy to planned drugs
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Comparison of the effects of propofol and nasal dexmedetomidine are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ahmed Uslu
Ankara, Çankaya, 06490, Turkey (Türkiye)